On ECHEMI
Home > Drugs > Tranilast Capsules

Tranilast Capsules

Function and Efficacy

It stabilizes the cell membranes of mast cells and basophils, preventing their degranulation, thereby inhibiting the release of histamine and 5-hydroxytryptamine allergic reaction substances. It has a significant inhibitory effect on skin allergic reactions and experimental asthma in rats caused by 1gE antibodies.

Ingredients

Tranilast

Name Description Content CAS NO. Manufacturer
TranilastIngredients

It stabilizes the cell membranes of mast cells and basophils, preventing their degranulation, thereby inhibiting the release of histamine and 5-hydroxytryptamine allergic reaction substances. It has a significant inhibitory effect on skin allergic reactions and experimental asthma in rats caused by 1gE antibodies.

More
53902-12-8 2

Appearance

This product is a capsule containing light yellow powder; it is odorless and tasteless.

Indication

This product is an antiallergic drug and can be used for the preventive treatment of bronchial asthma and allergic rhinitis.

Usage and Dosage

Oral administration. Generally, adults take 1 tablet (0.1 g) 3 times a day; children take 5 mg/kg a day, divided into 3 doses. It can be used in combination with other antiasthmatic drugs during asthma attacks, or as directed by a doctor.

Adverse Reactions

1 Liver: Occasionally, abnormal liver function may occur, which requires careful observation. Appropriate measures such as dosage reduction or drug discontinuation may be taken. 2 Gastrointestinal: Lack of appetite, nausea, vomiting, abdominal pain, bloating, constipation, diarrhea, stomach discomfort, and occasionally a feeling of indigestion may be found. 3 Blood: There may be a decrease in the number of red blood cells and hemoglobin. 4 Mental and nervous system: Symptoms such as headache, drowsiness, occasional heavy head, insomnia, dizziness, and general fatigue. 5 Allergic reactions: Skin rash, occasional allergic symptoms such as itching all over the body, in which case the drug should be discontinued. 6 Urinary system: Occasionally, symptoms of bladder irritation may occur, and the drug should be discontinued. 7 Others: Occasionally, symptoms such as palpitations, edema, facial flushing, nosebleeds, and stomatitis may occur.

Precautions

Pregnant women should not use it, and those with abnormal liver and kidney function should use it with caution.

Special Population Medication

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Pregnant women should not use. Precautions for the elderly: Not yet clear.

Drug Interactions

Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.

Storage

Sealed, store in a dry place.

Packaging Specification

0.1 g

Validity Period

24 months

Manufacturer

NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

  • Founded in:

    1989-01-25
  • Address:

    No. 8 Kunming Lake Street, Shenyang Economic and Technological Development Zone
  • Tax NO.:

    91210106242656694M
  • Registered Funds:

    80 million yuan
  • Website:

  • Email:

Other Drugs of NORTHEAST Pharmaceutical Group Shenyang NO.1 Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.